Rivaroxaban
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from Xarelto)
 | This article is a stub. |
Rivaroxaban is a novel oral anticoagulant (NOAC) drug and a Factor Xa inhibitor, which is sold under the brand name Xarelto.[1]
Theory[edit | edit source]
Evidence[edit | edit source]
Clinicians[edit | edit source]
Risks and safety[edit | edit source]
Costs and availability[edit | edit source]
See also[edit | edit source]
Learn more[edit | edit source]
- Rivaroxaban - drugs.com
- Rivaroxaban - MedlinePlus
- StatPearls
- Xarelto - Drug website
References[edit | edit source]
- ↑ "Rivaroxaban Uses, Side Effects & Warnings". Drugs.com. Retrieved August 2, 2022.
